- Joined
- Aug 6, 2013
- Messages
- 414
- Reaction score
- 670
Yes, there is retrospective data that does not attempt to (or does not adequately) control for co-morbidities that shows patients undergoing RP live longer.
That may be the 'critical review' standard for urologists citing literature, but every Rad Onc knows who is more likely to get a RP and who is more likely to get ADT+RT out of a high-risk prostate cancer population, and how that influences survival much more than the choice of treatment modality does.
Yeah I wasn't saying I agree with them by any stretch, just that RP for high risk disease isn't necessarily absurd. If I was 50 with low volume low psa organ confined Gleason 8 disease, I would seriously consider surgery.